Back Pain Doctor
Osteoporosis
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Osteoporosis means the bones become thinner and weaker and break more easily. It develops silently over years, and often the first sign is a fracture from a minor injury, commonly of the wrist, spine or hip. Because it is symptomless until then, the goal is to identify and treat those at risk before a fracture occurs.
Fracture-risk assessment is a core part of preventive practice. A DXA scan measures bone density and is Medicare-rebated in defined situations (for example, age 70 and over, after a minimal-trauma fracture, or with certain conditions or medications). Risk calculators such as FRAX or Garvan help guide decisions, and a fracture from minimal trauma after 50 itself warrants assessment and usually treatment.
Management combines lifestyle and medical measures: adequate dietary calcium and vitamin D, weight-bearing and resistance exercise, stopping smoking, limiting alcohol, and falls prevention, alongside PBS-subsidised medicines (such as bisphosphonates, denosumab and anabolic agents) for those at higher risk. Treatment is individualised, and menopausal hormone therapy is an option for some women. Ongoing review with a GP ties this together.
Common symptoms
- Often no symptoms until a bone breaks
- A fracture from a minor injury, such as a fall from standing height
- Loss of height or a stooped posture over time
- Back pain from a spinal compression fracture
Commonly seen in
Evidence for twelve treatment options in osteoporosis
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Load is what builds bone; nothing else offered here does. A meta-analysis of 80 studies and 5,581 postmenopausal women found exercise improved bone mineral density at the lumbar spine, femoral neck and total hip, and that supervision was not required for the effect (Mohebbi, Osteoporos Int 2023). A network meta-analysis of 97 trials found every exercise type beat no exercise at the femoral neck, with resistance training ranking best for total hip (Zhang, J Clin Nurs 2021). Moderate-to-high impact loading also improves bone structure, not just density, and the effect is site-specific. It accrues where the load is applied (Ng, J Bone Miner Res 2023).
Pairing reviewed 2026-09-02.
Where it fits
For a bone stress injury the sequence is relative rest until it settles, then a graded return to load that is progressed slowly enough for the bone to keep up. For bone density, the loading is the treatment and it has to continue. The gains reverse when it stops. Energy availability, vitamin D and medical contributors are assessed alongside it.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
Trigger-point injection reviews address confirmed myofascial pain and find heterogeneous, generally low-certainty results; they do not establish the technique as treatment for the underlying diagnosis. Condition reviewed: osteoporosis.
Evidence source: Debrosse et al., trigger-point injection systematic review (2022)
Pairing reviewed 2026-08-30.
Where it fits
For osteoporosis, this may be considered only when examination finds a separate tender muscle band reproducing part of the pain. It does not treat the primary pathology and is used to help movement or rehabilitation.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. Only if relevant
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
Ultrasound improves needle-placement accuracy, but guidance is not a treatment in itself: benefit depends on a valid injectable target and what is injected. Condition reviewed: osteoporosis.
Evidence source: Oo et al., ultrasound-guided injection systematic review (2024)
Pairing reviewed 2026-08-30.
Where it fits
For osteoporosis, an ultrasound-guided injection is considered only when there is a specific diagnostic question or a separate joint, bursa, sheath or nerve target. The injectate and purpose are stated before treatment.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Not offered for this
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
Not appropriate over a systemic inflammatory process, healing bone, an area of osteonecrosis or a complete tendon or ligament rupture.
Pairing reviewed 2026-08-30.
Where it fits
Not offered for this.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Laboratory studies only
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Radial shockwave has not been tested as a treatment for osteoporosis in people. A search on 11 November 2026 for radial shockwave with osteoporosis or bone mineral density returned 19 records, all read: cell, animal and modelling studies, such as improved bone structure in rats after removal of the ovaries (Inoue, Calcif Tissue Int 2021), plus reports in other bone conditions, and no human study of bone density. A wider search for human trials of any shockwave device (16 records) found two that measured bone density, neither stating a radial device. In 64 postmenopausal women all taking alendronate, a single higher-energy session to one hip was followed by a larger gain in hip bone density at twelve months than in controls (Shi, Osteoporos Int 2017). A pilot using an unfocused device on one forearm in twelve women without bone disease found no change (Koolen, Arch Osteoporos 2019). Neither measured fractures.
Pairing reviewed 2026-11-11.
Where it fits
Not a treatment for bone density or fracture risk. Considered only for a separate muscle or tendon problem.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. Only if relevant
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
Not a treatment for bone density. Two human trials have measured bone density after shockwave, and neither measured fractures. In 64 postmenopausal women with osteoporosis, all taking alendronate, a single higher-energy session to one hip was followed by a larger gain in hip bone density at twelve months than in untreated controls or in a lower-energy group; the abstract does not state the type of device (Shi, Osteoporos Int 2017). A pilot applying an unfocused device to one forearm in twelve women without bone disease found no change in bone density or bone mineral content at six and twelve weeks (Koolen, Arch Osteoporos 2019). That is one small positive trial with a single treated site and one negative pilot. The established bone evidence for shockwave is in nonunion, resistant stress fracture and osteonecrosis.
Pairing reviewed 2026-11-11.
Where it fits
Considered only where one of those specific problems is present.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Only if relevant
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
No evidence in this condition, and the rationale offered for EMTT (an effect on tendon and soft-tissue cell behaviour) does not apply to a systemic, bone or complete structural problem.
Pairing reviewed 2026-08-30.
Where it fits
Not part of the plan here.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Only for a separate problem
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
No study in people has tested PRP as a treatment for osteoporosis or low bone density. A PubMed search in October 2026 pairing platelet-rich plasma with osteoporosis, osteopenia and bone mineral density returned 31 records once animal and laboratory work was excluded, and none measures bone density in people after PRP. What has been tested is PRP added to surgery for the fractures osteoporosis causes, and it did not help. In 200 people aged 65 and over having a broken hip fixed with screws, PRP injected into the fracture did not reduce the need for repeat surgery within a year (an absolute difference of 5.6%, 95% CI -10.6% to 21.8%) (Griffin, BMJ Open 2013). In 84 people aged 60 and over having a hip fracture fixed with a nail, PRP gave a better X-ray healing score at two weeks only, with no difference in healing or function from six weeks to six months (Tantavisut, Orthop Traumatol Surg Res 2026).
Pairing reviewed 2026-10-12.
Where it fits
Not a treatment for bone density. Loading exercise, nutrition, falls prevention and, where indicated, bone-protective medication are what reduce fracture risk. PRP is considered only for a separate tendon or joint problem, on that problem's own evidence.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Not a bone-density treatment
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
No study has tested prolotherapy as a treatment for osteoporosis or bone density. PubMed searches on 17 October 2026 (prolotherapy, dextrose injection, hypertonic dextrose or hypertonic glucose with osteoporosis, osteoporotic, bone mineral density or fragility fracture, then randomised-trial and systematic-review passes) returned two case reports in which the patient happened to have osteoporosis and was treated for something else (a knee arthritis case, Yoon, Cureus 2026; a nerve entrapment case managed with exercise, Ozuberk, J Med Case Rep 2024).
Pairing reviewed 2026-10-17.
Where it fits
Not a treatment for osteoporosis, which is managed with bone-protective medicines, strength and impact training, calcium, vitamin D and falls prevention. Prolotherapy is considered only for a separate ligament or tendon problem, assessed on its own evidence.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Only if relevant
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
Hyaluronic acid evidence is concentrated in osteoarthritis (especially the knee) and remains contested; it cannot be extrapolated to a non-arthritic tissue or a different diagnosis. Condition reviewed: osteoporosis.
Evidence source: Pereira et al., large-trial injection review (2024)
Pairing reviewed 2026-08-30.
Where it fits
For osteoporosis, this is relevant only when a symptomatic arthritic peripheral joint is the actual target. It is not used for muscle, tendon, ligament, nerve, fracture or spinal pathology.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Only if relevant
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
Perineural dextrose evidence is concentrated in diagnosed peripheral compression neuropathies, particularly the upper limb; no direct evidence was identified for this diagnosis itself. Condition reviewed: osteoporosis.
Evidence source: Perineural dextrose for upper-limb entrapment neuropathy review (2025)
Pairing reviewed 2026-08-30.
Where it fits
For osteoporosis, perineural treatment may be considered only if a separate superficial neuropathic pain pattern is found on examination. It is not treatment of the primary diagnosis.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
Hydrodissection evidence is concentrated in ultrasound-confirmed peripheral nerve entrapment, especially carpal tunnel syndrome; no direct evidence was identified for this diagnosis itself. Condition reviewed: osteoporosis.
Evidence source: Buntragulpoontawee et al., hydrodissection injectate review (2021)
Pairing reviewed 2026-08-30.
Where it fits
For osteoporosis, hydrodissection may be considered only if ultrasound and examination identify a separate compressed or tethered peripheral nerve. It is not treatment of the primary diagnosis.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other general conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Related articles
Shorter articles that answer the questions patients ask most often about this.
Frequently asked questions
How is osteoporosis diagnosed?
How is it treated?
Who should be assessed?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment